Medical Properties Trust (NYSE:MPW) Cut to “Hold” at ValuEngine

ValuEngine downgraded shares of Medical Properties Trust (NYSE:MPW) from a buy rating to a hold rating in a research report report published on Thursday morning, ValuEngine reports.

Several other brokerages have also recently weighed in on MPW. Zacks Investment Research cut Medical Properties Trust from a hold rating to a sell rating in a research note on Wednesday, July 17th. Deutsche Bank raised Medical Properties Trust from a hold rating to a buy rating in a research note on Monday, July 29th. Stifel Nicolaus raised Medical Properties Trust from a hold rating to a buy rating and upped their price target for the stock from $18.00 to $19.00 in a research note on Tuesday, July 23rd. Finally, SunTrust Banks raised Medical Properties Trust from a hold rating to a buy rating and upped their price target for the stock from $19.00 to $20.00 in a research note on Tuesday, July 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $18.69.

MPW stock traded up $0.02 during midday trading on Thursday, hitting $17.87. The stock had a trading volume of 3,282,856 shares, compared to its average volume of 6,792,113. The stock has a market cap of $7.04 billion, a price-to-earnings ratio of 13.04, a price-to-earnings-growth ratio of 2.84 and a beta of 0.60. The stock’s 50-day moving average price is $17.96. Medical Properties Trust has a 52-week low of $13.98 and a 52-week high of $18.92. The company has a current ratio of 8.00, a quick ratio of 9.37 and a debt-to-equity ratio of 0.99.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.31. The company had revenue of $192.55 million for the quarter, compared to analysts’ expectations of $186.11 million. Medical Properties Trust had a return on equity of 6.84% and a net margin of 129.20%. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.36 earnings per share. Equities research analysts expect that Medical Properties Trust will post 1.32 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Thursday, June 13th were paid a $0.25 dividend. The ex-dividend date was Wednesday, June 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.60%. Medical Properties Trust’s dividend payout ratio is currently 72.99%.

In other news, Director Michael G. Stewart sold 6,830 shares of the stock in a transaction on Friday, June 7th. The stock was sold at an average price of $18.47, for a total value of $126,150.10. Following the sale, the director now directly owns 224,615 shares of the company’s stock, valued at $4,148,639.05. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.18% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MPW. First Interstate Bank purchased a new stake in shares of Medical Properties Trust in the first quarter worth $32,000. Cullen Frost Bankers Inc. lifted its holdings in shares of Medical Properties Trust by 70.9% during the second quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 760 shares in the last quarter. Manchester Financial Inc. bought a new position in shares of Medical Properties Trust during the second quarter valued at $33,000. Cascade Investment Advisors Inc. bought a new position in shares of Medical Properties Trust during the second quarter valued at $35,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Medical Properties Trust during the first quarter valued at $37,000. 80.52% of the stock is currently owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: What is Net Asset Value (NAV)?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.